252 related articles for article (PubMed ID: 36746729)
1. Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study.
Zattoni F; Marra G; Martini A; Kasivisvanathan V; Grummet J; Harkin T; Ploussard G; Olivier J; Chiu PK; Valerio M; Marquis A; Gontero P; Guo H; Zhuang J; Frydenberg M; Moon D; Morlacco A; Kretschmer A; Barletta F; Heidegger I; Tilki D; van den Bergh R; Dal Moro F; Briganti A; Montorsi F; Novara G; Gandaglia G;
Eur Urol Focus; 2023 Jul; 9(4):621-628. PubMed ID: 36746729
[TBL] [Abstract][Full Text] [Related]
2. The Detection of Prostate Cancer with Magnetic Resonance Imaging-Targeted Prostate Biopsies is Superior with the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-Institutional Study.
Zattoni F; Marra G; Kasivisvanathan V; Grummet J; Nandurkar R; Ploussard G; Olivier J; Chiu PK; Valerio M; Gontero P; Guo H; Zhuang J; Barletta F; Leni R; Frydenberg M; Moon D; Hanegbi U; Landaumailto A; Snow R; Apfelbeck M; Kretschmer A; van den Bergh R; Novara G; Briganti A; Dal Moro F; Gandaglia G
J Urol; 2022 Oct; 208(4):830-837. PubMed ID: 36082555
[TBL] [Abstract][Full Text] [Related]
3. Gleason Grade Group Concordance between Systematic Template Combining Magnetic Resonance Imaging Fusion Targeted Biopsy and Radical Prostatectomy Specimens: A Comparison of Transperineal and Transrectal Approaches.
Wu S; Feldman AS; Kim MM; Lin SX; Cornejo KM; Harisinghani MG; Dahl DM; Wu CL
Urology; 2023 May; 175():151-156. PubMed ID: 36828261
[TBL] [Abstract][Full Text] [Related]
4. Direct comparison between Grade Group assessed on systematic and MRI/ultrasound fusion targeted biopsies correlated to the radical prostatectomy specimens in patients with prostate cancer.
Payrard-Starck C; Fourcade A; An Nguyen T; Tissot V; Doucet L; Marolleau J; Lucas C; Fournier G; Valeri A
Prog Urol; 2023 Apr; 33(5):265-271. PubMed ID: 36740508
[TBL] [Abstract][Full Text] [Related]
5. Gleason grade accuracy of transperineal and transrectal prostate biopsies in MRI-naïve patients.
Qu LG; Al-Shawi M; Howard T; Papa N; Poyet C; Kelly B; Egan AJM; Lawrentschuk N; Bolton D; Jack GS
Int Urol Nephrol; 2021 Dec; 53(12):2445-2452. PubMed ID: 34623591
[TBL] [Abstract][Full Text] [Related]
6. Concordance Between Biopsy and Radical Prostatectomy Pathology in the Era of Targeted Biopsy: A Systematic Review and Meta-analysis.
Goel S; Shoag JE; Gross MD; Al Hussein Al Awamlh B; Robinson B; Khani F; Baltich Nelson B; Margolis DJ; Hu JC
Eur Urol Oncol; 2020 Feb; 3(1):10-20. PubMed ID: 31492650
[TBL] [Abstract][Full Text] [Related]
7. The eternal enigma in prostatic biopsy access route.
Fabiani A; Principi E; Filosa A; Servi L
Arch Ital Urol Androl; 2017 Oct; 89(3):245-246. PubMed ID: 28969413
[TBL] [Abstract][Full Text] [Related]
8. Comparison of TRUS and combined MRI-targeted plus systematic prostate biopsy for the concordance between biopsy and radical prostatectomy pathology.
Aslan G; Çelik S; Sözen S; Akdoğan B; İzol V; Yücel Bilen C; Sahin B; Türkeri L;
Int J Clin Pract; 2021 Mar; 75(3):e13797. PubMed ID: 33113261
[TBL] [Abstract][Full Text] [Related]
9. Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis.
Weinstein IC; Wu X; Hill A; Brennan D; Omil-Lima D; Basourakos S; Brant A; Lewicki P; Al Hussein Al Awamlh B; Spratt D; Bittencourt LK; Scherr D; Zaorsky NG; Nagar H; Hu J; Barbieri C; Ponsky L; Vickers AJ; Shoag JE
Eur Urol Oncol; 2023 Aug; 6(4):355-365. PubMed ID: 37236832
[TBL] [Abstract][Full Text] [Related]
10. PI-RADS Version 2.0 Versus Version 2.1: Comparison of Prostate Cancer Gleason Grade Upgrade and Downgrade Rates From MRI-Targeted Biopsy to Radical Prostatectomy.
Yilmaz EC; Lin Y; Belue MJ; Harmon SA; Phelps TE; Merriman KM; Hazen LA; Garcia C; Johnson L; Lay NS; Toubaji A; Merino MJ; Patel KR; Parnes HL; Law YM; Wood BJ; Gurram S; Choyke PL; Pinto PA; Turkbey B
AJR Am J Roentgenol; 2024 Jan; 222(1):e2329964. PubMed ID: 37729551
[No Abstract] [Full Text] [Related]
11. The impact of mpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology.
Sorce G; Stabile A; Pellegrino F; Mazzone E; Mattei A; Afferi L; Serni S; Minervini A; Roumiguiè M; Malavaud B; Valerio M; Rakauskas A; Marra G; Gontero P; Porpiglia F; Guo H; Zhuang J; Gandaglia G; Montorsi F; Briganti A
World J Urol; 2024 Apr; 42(1):248. PubMed ID: 38647689
[TBL] [Abstract][Full Text] [Related]
12. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1).
Ploussard G; Barret E; Fiard G; Lenfant L; Malavaud B; Giannarini G; Almeras C; Aziza R; Renard-Penna R; Descotes JL; Rozet F; Beauval JB; Salin A; Rouprêt M
Eur Urol Oncol; 2024 Feb; ():. PubMed ID: 38403523
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the optimal strategy in men with a single unilateral suspicious lesion on MRI undergoing transperineal MRI/ultrasound fusion prostate biopsy.
Yusim I; Mazor E; Frumkin E; Jabareen M; Hefer B; Elsaraya N; Li S; Rouvinov K; Novack V; Mabjeesh NJ
Prostate; 2023 Sep; 83(13):1255-1262. PubMed ID: 37263774
[TBL] [Abstract][Full Text] [Related]
14. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Moschini M; Zamboni S; Rakauskas A; Tian Z; Karakiewicz PI; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
Eur Urol; 2020 Jun; 77(6):733-741. PubMed ID: 31547938
[TBL] [Abstract][Full Text] [Related]
15. Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy in Clinically Significant Prostate Cancer Detection Rate? A Systematic Review and Meta-analysis.
Uleri A; Baboudjian M; Tedde A; Gallioli A; Long-Depaquit T; Palou J; Basile G; Gaya JM; Sanguedolce F; Lughezzani G; Rajwa P; Pradere B; Roupret M; Briganti A; Ploussard G; Breda A
Eur Urol Oncol; 2023 Dec; 6(6):621-628. PubMed ID: 37634971
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging target fusion biopsy vs. transrectal ultrasound-guided biopsy - A comparative study of ISUP score upgrading risk in the final radical prostatectomy specimen.
Guimarães T; Gil M; Medeiros M; Andrade V; Guerra J; Pinheiro H; Fernandes F; Pina J; Lopes Dias J; Campos Pinheiro L
Arch Ital Urol Androl; 2022 Sep; 94(3):278-284. PubMed ID: 36165470
[TBL] [Abstract][Full Text] [Related]
17. Transperineal versus transrectal prostate biopsy for predicting the final laterality of prostate cancer: are they reliable enough to select patients for focal therapy? Results from a multicenter international study.
Miano R; De Nunzio C; Kim FJ; Rocco B; Gontero P; Vicentini C; Micali S; Oderda M; Masciovecchio S; Asimakopoulos AD
Int Braz J Urol; 2014; 40(1):16-22. PubMed ID: 24642146
[TBL] [Abstract][Full Text] [Related]
18. Targeted Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy for Quantitative Gleason 4 Grading Prediction in Radical Prostatectomy Specimens: Implications for Active Surveillance Candidate Selection.
Kachanov M; Budäus L; Beyersdorff D; Karakiewicz PI; Tian Z; Falkenbach F; Tilki D; Maurer T; Sauter G; Graefen M; Leyh-Bannurah SR
Eur Urol Focus; 2023 Mar; 9(2):303-308. PubMed ID: 36184537
[TBL] [Abstract][Full Text] [Related]
19. Suitability of conventional systematic vs. MRI-guided targeted biopsy approaches to assess surgical treatment delay for radical prostatectomy.
Kachanov M; Budäus L; Witt JH; Wagner C; Zinke J; Fangmeyer B; Schütte A; Spieker T; Beyersdorff D; Graefen M; Rachubinski P; Leyh-Bannurah SR
World J Urol; 2022 Dec; 40(12):2955-2961. PubMed ID: 36357604
[TBL] [Abstract][Full Text] [Related]
20. The role of perilesional and multiparametric resonance imaging-targeted biopsies to reduce the risk of upgrading at radical prostatectomy pathology: A retrospective monocentric study.
Diamand R; Hollans M; Lefebvre Y; Sirtaine N; Limani K; Hawaux E; Abou Zahr R; Mattlet A; Albisinni S; Roumeguère T; Peltier A
Urol Oncol; 2022 May; 40(5):192.e11-192.e17. PubMed ID: 35236622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
